Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12621000231842Phase 3Completed
Phase 3, randomised, double-blind trial in intrapartum asphyxia comparing Sildenafil citrate with Placebo (2 arms). Primary endpoint: Primary composite endpoint. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12621000231842.